Epidemiology of methicillin-resistant Staphylococcus aureus.

By H. Boucher, G. Corey. Clinical Infectious Diseases, 2008

1,034 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States (2019, background): “Methicillin-resistant S. aureus (MRSA) has long been recognized as a pathogen associated with health care settings; however, in the 1990s, community-associated MRSA infections, causing mostly SSTI, emerged in the United States (2).”
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. (2010, background): “In 2005, MRSA caused 94,360 severe invasive infections and resulted in 18,650 deaths in the US, exceeding the annual number of deaths in the US caused by HIV/AIDS, tuberculosis, and viral hepatitis combined (4, 5).”
Hospital Epidemiology and Infection Control in Acute-Care Settings (2011, background): “sports, and being a man who has sex with men (30, 176).”
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (2009, background): “More people now die of MRSA infection in US hospitals than of HIV/AIDS and tuberculosis combined [5, 6].”